Amdocs Limited (NASDAQ: DOX) today reported operating results for
the three months ended December 31, 2019.
“We are pleased to report a solid start to the fiscal year, with
record revenue driven by sequential growth in North America, and
healthy year-over-year trends in Europe and Rest of World.
Profitability was consistent with our operating plan, including
investments to support the ramp-up of new activities at AT&T
and other customers, and we returned more than 100% of normalized
free cash flow to shareholders through our share repurchases and
quarterly dividend payment programs,” said Shuky Sheffer, president
and chief executive officer of Amdocs Management Limited.
Sheffer continued, “During Q1, we secured pivotal new wins that
extend our core market leadership in key domains such as digital
modernization and customer experience. Earlier in the quarter, we
announced that Vodafone Germany had selected Amdocs for a strategic
transformation project, and we have followed this today with the
signing of a large-scale managed transformation award at Orange
Spain and a multi-year managed services agreement with A1 Bulgaria,
a subsidiary of the A1 Telekom Austria Group. In Rest of World,
Korea Telecom has selected Amdocs CatalogONE to further accelerate
the introduction and monetization of new 5G consumer and enterprise
offerings in the South Korean market. This important new award will
allow KT to strengthen its position as a global leader in 5G
adoption and is consistent with the growing industry demand we are
seeing for 5G monetization capabilities that are deployed on the
cloud.”
Sheffer concluded, “Turning to the outlook, we expect revenue
growth to accelerate in the fiscal second half as new customer
activity ramps-up. Our visibility is supported by record 12-month
backlog of $3.5 billion, which is up 4.5% from a year ago, and we
have slightly increased our full year outlook for free cash flow
generation. Overall, we are on-track to deliver total expected
shareholder returns2 in the mid-to-high single digits for the
eighth consecutive year in fiscal 2020.”
Revenue
Revenue for the first fiscal quarter ended December 31, 2019 was
$1,042 million, up $12 million sequentially from the fourth fiscal
quarter of 2019 and up 3.0% as reported and 3.1% in constant
currency as compared to last year’s first fiscal quarter. Revenue
for the first fiscal quarter of 2020 includes a positive impact
from foreign currency movements of approximately $3 million
relative to the fourth quarter of fiscal 2019. Revenue was above
the midpoint of Amdocs’ guidance, adjusting for the positive impact
of approximately $4 million of foreign currency movements relative
to guidance.
Net Income and Earnings Per Share
The Company's GAAP net income for the first quarter of fiscal
2020 was $115.9 million, or $0.85 per diluted share, compared to
GAAP net income of $101.7 million, or $0.72 per diluted share, in
the prior fiscal year’s first quarter. Net income on a non-GAAP
basis was $144.2 million, or $1.06 per diluted share, compared to
non-GAAP net income of $137.8 million, or $0.98 per diluted share,
in the first quarter of fiscal 2019. Non-GAAP net income excludes
amortization of purchased intangible assets and other
acquisition-related costs, changes in certain acquisitions related
liabilities measured at fair value, equity-based compensation
expenses, net of related tax effects, in the first quarter of
fiscal 2020 and in the first quarter of fiscal 2019.
For further details of reconciliation of selected financial
metrics from GAAP to Non-GAAP, please refer to the tables
below.
Returning Cash to Shareholders
- Quarterly Cash Dividend Program: On February
4, 2020, the Board approved the Company’s next quarterly cash
dividend payment of $0.3275 per share and set March 31, 2020 as the
record date for determining the shareholders entitled to receive
the dividend, which will be payable on April 24, 2020.
- Share Repurchase Activity: Repurchased $90
million of ordinary shares during the first quarter of fiscal
2020.
Twelve-month Backlog
Twelve-month backlog, which includes anticipated revenue related
to contracts, estimated revenue from managed services contracts,
letters of intent, maintenance and estimated on-going support
activities, was $3.52 billion at the end of the first quarter of
fiscal 2020, up $30 million from the end of the prior quarter.
Second Quarter Fiscal 2020
Outlook
- Revenue of approximately $1,035-$1,075 million, assuming
approximately $2 million sequential positive impact from foreign
currency fluctuations as compared to the first quarter of fiscal
2020
- GAAP diluted EPS of approximately $0.82-$0.90.
- Non-GAAP diluted EPS of approximately $1.03-$1.09, excluding
amortization of purchased intangible assets and other
acquisition-related costs, changes in certain acquisitions related
liabilities measured at fair value, and approximately $0.06-$0.08
per share of equity-based compensation expense, net of related tax
effects
Full Year Fiscal 2020
Outlook
- Expects revenue growth of 2.5%-5.5% year-over-year on a
reported basis as compared with 1.5%-5.5% year-over-year
previously
- Expects revenue growth of 2.5%-5.5% year-over-year on a
constant currency basis as compared with 2.0%-6.0% year-over-year
previously
- Full year fiscal 2020 revenue guidance incorporates just over
1% of growth from the acquisition of TTS Wireless, and an
immaterial impact from foreign currency fluctuations as compared
with a negative impact of about 0.5% year-over-year previously
- Reiterates GAAP diluted earnings per share growth of roughly
5.0%-12.0% year-over-year
- Reiterates non-GAAP diluted earnings per share growth of
roughly 3.0%-7.0% year-over-year, excluding amortization of
purchased intangible assets and other acquisition-related costs,
changes in certain acquisitions related liabilities measured at
fair value, and approximately $0.24-$0.30 per share of equity-based
compensation expense, net of related tax effects.
- Expects free cash flow of approximately $400 million, comprised
of cash flow from operations, less net capital expenditures and
other, as compared with $350 million previously
- Expects normalized free cash flow of approximately $500 million
as compared with $480 million previously; normalized free cash flow
excludes capital expenditure of up to $90 million related to the
new campus development in Israel, as compared with capital
expenditure of up to $120 million previously, and other items
Our second fiscal quarter 2020 and full year fiscal 2020 outlook
takes into consideration the Company’s expectations regarding macro
and industry specific risks and various uncertainties and certain
assumptions that we will discuss on our earnings conference call.
However, Amdocs notes market dynamics continue to shift rapidly and
that it cannot predict all possible outcomes, including those
resulting from T-Mobile’s proposed merger with Sprint, or from
other current and potential customer consolidation activity.
Conference Call Details
Amdocs will host a conference call on February 4, 2020 at 5:00
p.m. Eastern Time to discuss the Company's first quarter of fiscal
2020 results. To participate, please dial +1 (844) 513-7152, or +1
(508) 637-5600 outside the United States, approximately 15 minutes
before the call and enter passcode 4096989. The call will also be
carried live on the Internet via the Amdocs website,
www.amdocs.com.
Non-GAAP Financial Measures
This release includes non-GAAP diluted earnings per share and
other non-GAAP financial measures, including free cash flow and
normalized free cash flow, non-GAAP cost of revenue, non-GAAP
research and development, non-GAAP selling, general and
administrative, non-GAAP operating income, non-GAAP operating
margin, non-GAAP interest and other expenses, net, non-GAAP income
taxes, non-GAAP effective tax rate, non-GAAP net income and
non-GAAP diluted earnings per share growth. These non-GAAP measures
exclude the following items:
- amortization of purchased intangible assets and other
acquisition-related costs;
- changes in certain acquisition-related liabilities measured at
fair value;
- non-recurring and unusual charges;
- equity-based compensation expense;
- other; and
- tax effects related to the above.
Free cash flow equals cash generated by operating activities
less net capital expenditures and other, and normalized free cash
flow is adjusted to exclude net capital expenditures related to the
new campus development, payments for previously expensed
restructuring charges, payments for legal dispute settlement, and
payments of acquisition related liabilities. These non-GAAP
financial measures are not in accordance with, or an alternative
for, generally accepted accounting principles and may be different
from non-GAAP financial measures used by other companies. In
addition, these non-GAAP financial measures are not based on any
comprehensive set of accounting rules or principles. Amdocs
believes that non-GAAP financial measures have limitations in that
they do not reflect all of the amounts associated with Amdocs’
results of operations as determined in accordance with GAAP and
that these measures should only be used to evaluate Amdocs’ results
of operations in conjunction with the corresponding GAAP
measures.
Amdocs believes that the presentation of non-GAAP diluted
earnings per share and other financial measures, including free
cash flow and normalized free cash flow, non-GAAP cost of revenue,
non-GAAP research and development, non-GAAP selling, general and
administrative, non-GAAP operating income, non-GAAP operating
margin, non-GAAP interest and other expenses, net, non-GAAP income
taxes, non-GAAP effective tax rate, non-GAAP net income and
non-GAAP diluted earnings per share growth when shown in
conjunction with the corresponding GAAP measures, provides useful
information to investors and management regarding financial and
business trends relating to its financial condition and results of
operations, as well as the net amount of cash generated by its
business operations after taking into account capital spending
required to maintain or expand the business.
For its internal budgeting process and in monitoring the results
of the business, Amdocs’ management uses financial statements that
do not include amortization of purchased intangible assets and
other acquisition-related costs, changes in certain
acquisition-related liabilities measured at fair value,
non-recurring and unusual charges, equity-based compensation
expense, other and related tax effects. Amdocs’ management also
uses the foregoing non-GAAP financial measures, in addition to the
corresponding GAAP measures, in reviewing the financial results of
Amdocs. In addition, Amdocs believes that significant groups of
investors exclude these items in reviewing its results and those of
its competitors, because the amounts of the items between companies
can vary greatly depending on the assumptions used by an individual
company in determining the amounts of the items.
Amdocs further believes that, where the adjustments used in
calculating non-GAAP diluted earnings per share are based on
specific, identified amounts that impact different line items in
the Consolidated Statements of Income (including cost of revenue,
research and development, selling, general and administrative,
operating income, interest and other expenses, net, income taxes
and net income), it is useful to investors to understand how these
specific line items in the Consolidated Statements of Income are
affected by these adjustments. Please refer to the Reconciliation
of Selected Financial Metrics from GAAP to Non-GAAP tables
below.
Supporting Resources
- Keep up with Amdocs news by visiting the Company’s website
- Subscribe to Amdocs’ RSS Feed and follow us on Twitter,
Facebook, LinkedIn and YouTube
About Amdocs
Amdocs is a leading software and services provider to
communications and media companies of all sizes, accelerating the
industry’s dynamic and continuous digital transformation. With a
rich set of innovative solutions, long-term business relationships
with 350 communications and media providers, and technology and
distribution ties to 600 content creators, Amdocs delivers business
improvements to drive growth. Amdocs and its 25,000 employees serve
customers in over 85 countries. Listed on the NASDAQ Global Select
Market, Amdocs had revenue of $4.1 billion in fiscal 2019.
For more information, visit Amdocs at www.amdocs.com.
This press release includes information that constitutes
forward-looking statements made pursuant to the safe harbor
provision of the Private Securities Litigation Reform Act of 1995,
including statements about Amdocs’ growth and business results in
future quarters. Although we believe the expectations reflected in
such forward-looking statements are based upon reasonable
assumptions, we can give no assurance that our expectations will be
obtained or that any deviations will not be material. Such
statements involve risks and uncertainties that may cause future
results to differ from those anticipated. These risks include, but
are not limited to, the effects of general economic conditions,
Amdocs’ ability to grow in the business markets that it serves,
Amdocs’ ability to successfully integrate acquired businesses,
adverse effects of market competition, rapid technological shifts
that may render the Company's products and services obsolete,
potential loss of a major customer, our ability to develop
long-term relationships with our customers, and risks associated
with operating businesses in the international market. Amdocs may
elect to update these forward-looking statements at some point in
the future; however, Amdocs specifically disclaims any obligation
to do so. These and other risks are discussed at greater length in
Amdocs’ filings with the Securities and Exchange Commission,
including in our Annual Report on Form 20-F for the fiscal year
ended September 30, 2019 filed on December 16, 2019.
Contact: Matthew Smith Head of Investor
Relations Amdocs 314-212-8328 E-mail: dox_info@amdocs.com
______________________________________
(1) Please refer to the Selected Financial Metrics tables below
(figures may not sum because of rounding).
(2) Total expected shareholder return includes non-GAAP EPS
growth of 3% to 7% in fiscal 2020 plus dividend yield of ~1.8%
(assumes quarterly dividend rate of $0.3275 as approved by
shareholders at the annual meeting in January 2020)
|
AMDOCS LIMITED |
|
Consolidated Statements of Income (In
thousands, except per share data) |
|
|
|
|
|
Three months ended |
|
|
December 31, |
|
|
2019 |
|
2018 |
|
|
|
|
|
|
|
|
Revenue |
|
$ |
1,041,957 |
|
|
$ |
1,012,055 |
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
Cost of revenue |
|
|
686,312 |
|
|
|
662,568 |
|
Research and development |
|
|
67,311 |
|
|
|
68,686 |
|
Selling, general and administrative |
|
|
123,467 |
|
|
|
121,860 |
|
Amortization of purchased intangible assets and other |
|
|
21,290 |
|
|
|
25,844 |
|
|
|
|
898,380 |
|
|
|
878,958 |
|
Operating income |
|
|
143,577 |
|
|
|
133,097 |
|
|
|
|
|
|
Interest and other (expense)
income, net |
|
|
(352 |
) |
|
|
1,522 |
|
Income before income taxes |
|
|
143,225 |
|
|
|
134,619 |
|
|
|
|
|
|
Income taxes |
|
|
27,293 |
|
|
|
32,927 |
|
Net income |
|
$ |
115,932 |
|
|
$ |
101,692 |
|
Basic earnings per share |
|
$ |
0.86 |
|
|
$ |
0.73 |
|
Diluted earnings per share |
|
$ |
0.85 |
|
|
$ |
0.72 |
|
Basic weighted average number of
shares outstanding |
|
|
134,596 |
|
|
|
139,639 |
|
Diluted weighted average number
of shares outstanding |
|
|
135,617 |
|
|
|
140,511 |
|
Cash dividends declared per
share |
|
$ |
0.285 |
|
|
$ |
0.250 |
|
|
|
|
|
|
|
|
|
|
|
AMDOCS LIMITEDSelected Financial
Metrics(In thousands, except per share
data) |
|
|
|
|
|
Three months ended |
|
|
December 31, |
|
|
2019 |
|
2018 |
|
|
|
|
|
Revenue |
|
$ |
1,041,957 |
|
|
$ |
1,012,055 |
|
|
|
|
|
|
Non-GAAP operating income |
|
|
177,940 |
|
|
|
174,849 |
|
|
|
|
|
|
Non-GAAP net income |
|
|
144,155 |
|
|
|
137,818 |
|
|
|
|
|
|
Non-GAAP diluted earnings per
share |
|
$ |
1.06 |
|
|
$ |
0.98 |
|
|
|
|
|
|
Diluted weighted average
number of shares outstanding |
|
|
135,617 |
|
|
|
140,511 |
|
|
|
|
|
|
|
|
|
|
|
Free Cash Flows and Normalized Free Cash
Flow(In thousands) |
|
|
|
|
|
Three months ended |
|
|
December 31, |
|
|
2019 |
|
2018 |
|
|
|
|
|
Net Cash Provided by Operating Activities |
|
$ |
163,908 |
|
|
$ |
109,650 |
|
|
|
|
|
|
Purchase of property and equipment, net (*) |
|
|
(58,535 |
) |
|
|
(37,278 |
) |
|
|
|
|
|
Free Cash Flow |
|
|
105,373 |
|
|
|
72,372 |
|
|
|
|
|
|
Payments for legal dispute
settlement |
|
|
- |
|
|
|
55,000 |
|
|
|
|
|
|
Payments for previously
expensed restructuring charges |
|
|
1,516 |
|
|
|
6,625 |
|
|
|
|
|
|
Net capital expenditures
related to the new campus development |
|
|
13,937 |
|
|
|
2,054 |
|
|
|
|
|
|
Normalized Free Cash Flow |
|
|
120,826 |
|
|
|
136,051 |
|
|
|
|
|
|
|
|
|
|
(*) The amounts under "Purchase of property and
equipment, net”, include proceed from sale of property and
equipment of $373 and $31 for the three months ended 31 December
2019 and 2018, respectively.
|
AMDOCS LIMITEDReconciliation of Selected
Financial Metrics from GAAP to Non-GAAP(In
thousands) |
|
|
|
Three months endedDecember 31,
2019 |
|
|
|
Reconciliation items |
|
|
|
GAAP |
Amortization ofpurchasedintangibleassets
andother |
Equity basedcompensationexpense |
Changes incertainacquisitionsrelated liabilitiesmeasured at
fairvalue |
Tax effect
|
Non-GAAP |
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenue |
$ |
686,312 |
$ |
- |
|
$ |
(5,346 |
) |
$ |
(2,312 |
) |
$ |
- |
|
$ |
678,654 |
Research and development |
|
67,311 |
|
- |
|
|
(803 |
) |
|
- |
|
|
- |
|
|
66,508 |
Selling, general and administrative |
|
123,467 |
|
- |
|
|
(4,612 |
) |
|
- |
|
|
- |
|
|
118,855 |
Amortization of purchased intangible assets and other |
|
21,290 |
|
(21,290 |
) |
|
- |
|
|
- |
|
|
- |
|
|
- |
Total
operating expenses |
|
898,380 |
|
(21,290 |
) |
|
(10,761 |
) |
|
(2,312 |
) |
|
- |
|
|
864,017 |
|
|
|
|
|
|
|
Operating income |
|
143,577 |
|
21,290 |
|
|
10,761 |
|
|
2,312 |
|
|
- |
|
|
177,940 |
|
|
|
|
|
|
|
Income taxes |
|
27,293 |
|
- |
|
|
- |
|
|
- |
|
|
6,140 |
|
|
33,433 |
|
|
|
|
|
|
|
Net income |
$ |
115,932 |
$ |
21,290 |
|
$ |
10,761 |
|
$ |
2,312 |
|
$ |
(6,140 |
) |
$ |
144,155 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months endedDecember 31,
2018 |
|
|
Reconciliation items |
|
|
|
GAAP |
Amortization ofpurchasedintangibleassets
andother |
Equity basedcompensationexpense |
Changes incertainacquisitionsrelated liabilitiesmeasured at
fairvalue |
Taxeffect
|
Non-GAAP |
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
Cost of revenue |
$ |
662,568 |
$ |
- |
|
$ |
(4,851 |
) |
$ |
(3,791 |
) |
$ |
- |
|
$ |
653,926 |
Research and development |
|
68,686 |
|
- |
|
|
(765 |
) |
|
- |
|
|
- |
|
|
67,921 |
Selling, general and administrative |
|
121,860 |
|
- |
|
|
(6,501 |
) |
|
- |
|
|
- |
|
|
115,359 |
Amortization of purchased intangible assets and other |
|
25,844 |
|
(25,844 |
) |
|
- |
|
|
- |
|
|
- |
|
|
- |
Total operating expenses |
|
878,958 |
|
(25,844 |
) |
|
(12,117 |
) |
|
(3,791 |
) |
|
- |
|
|
837,206 |
|
|
|
|
|
|
|
|
|
|
|
|
Operating income |
|
133,097 |
|
25,844 |
|
|
12,117 |
|
|
3,791 |
|
|
- |
|
|
174,849 |
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes |
|
32,927 |
|
- |
|
|
- |
|
|
- |
|
|
5,626 |
|
|
38,553 |
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
$ |
101,692 |
$ |
25,844 |
|
$ |
12,117 |
|
$ |
3,791 |
|
$ |
(5,626 |
) |
$ |
137,818 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AMDOCS LIMITEDCondensed Consolidated
Balance Sheets(In thousands) |
|
|
|
|
|
As of |
|
|
December 31, 2019 |
|
September 30, 2019 |
|
|
|
|
|
ASSETS |
|
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
Cash and cash
equivalents |
|
$ |
485,875 |
|
|
$ |
471,632 |
|
Accounts receivable, net,
including unbilled of $205,080 and $227,061, respectively |
|
|
1,002,264 |
|
|
|
987,858 |
|
Prepaid expenses and other
current assets |
|
|
223,385 |
|
|
|
216,084 |
|
Total current assets |
|
|
1,711,524 |
|
|
|
1,675,574 |
|
|
|
|
|
|
Property and equipment, net |
|
|
538,709 |
|
|
|
525,314 |
|
Lease assets |
|
|
280,670 |
|
|
|
- |
|
Goodwill and other intangible
assets, net |
|
|
2,645,341 |
|
|
|
2,667,997 |
|
Other noncurrent assets |
|
|
456,031 |
|
|
|
423,941 |
|
Total assets |
|
$ |
5,632,275 |
|
|
$ |
5,292,826 |
|
|
|
|
|
|
LIABILITIES AND
SHAREHOLDERS’ EQUITY |
|
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
Accounts payable, accruals and
other |
|
$ |
1,076,333 |
|
|
$ |
1,089,748 |
|
Lease liabilities |
|
|
57,752 |
|
|
|
- |
|
Deferred revenue |
|
|
134,401 |
|
|
|
118,182 |
|
Total current liabilities |
|
|
1,268,486 |
|
|
|
1,207,930 |
|
Lease liabilities |
|
|
223,664 |
|
|
|
- |
|
Other noncurrent liabilities |
|
|
558,321 |
|
|
|
542,430 |
|
Total Amdocs Limited
Shareholders’ equity |
|
|
3,539,295 |
|
|
|
3,499,957 |
|
Noncontrolling interests |
|
|
42,509 |
|
|
|
42,509 |
|
Total equity |
|
|
3,581,804 |
|
|
|
3,542,466 |
|
Total liabilities and equity |
|
$ |
5,632,275 |
|
|
$ |
5,292,826 |
|
|
|
|
|
|
|
|
|
|
|
AMDOCS LIMITEDConsolidated Statements of
Cash Flows(In thousands) |
|
|
|
|
|
Three months ended December
31, |
|
|
2019 |
|
2018 |
|
|
|
|
|
Cash Flow from Operating Activities: |
|
|
|
|
Net
income |
|
$ |
115,932 |
|
|
$ |
101,692 |
|
Reconciliation of net income to net cash provided by operating
activities: |
|
|
|
|
Depreciation and amortization |
|
|
48,999 |
|
|
|
51,477 |
|
Equity-based compensation expense |
|
|
10,761 |
|
|
|
12,117 |
|
Deferred income taxes |
|
|
6,359 |
|
|
|
(4,505 |
) |
Gain from short-term interest-bearing investments |
|
|
- |
|
|
|
(30 |
) |
Net changes in operating assets and liabilities, net of amounts
acquired: |
|
|
|
|
Accounts receivable, net |
|
|
(34,693 |
) |
|
|
(26,406 |
) |
Prepaid expenses and other current assets |
|
|
(10,114 |
) |
|
|
20,174 |
|
Other noncurrent assets |
|
|
(366 |
) |
|
|
2,552 |
|
Lease assets and liabilities, net |
|
|
(870 |
) |
|
|
- |
|
Accounts payable, accrued expenses and accrued personnel |
|
|
9,737 |
|
|
|
(50,332 |
) |
Deferred revenue |
|
|
12,855 |
|
|
|
(11,922 |
) |
Income taxes payable, net |
|
|
1,446 |
|
|
|
23,887 |
|
Other noncurrent liabilities |
|
|
3,862 |
|
|
|
(9,054 |
) |
Net cash provided by operating activities |
|
|
163,908 |
|
|
|
109,650 |
|
|
|
|
|
|
Cash Flow from Investing Activities: |
|
|
|
|
Purchase of property and equipment, net (*) |
|
|
(58,535 |
) |
|
|
(37,278 |
) |
Proceeds from sale of short-term interest-bearing
investments |
|
|
- |
|
|
|
860 |
|
Net cash paid for acquisitions |
|
|
- |
|
|
|
(8,331 |
) |
Other |
|
|
(2,458 |
) |
|
|
857 |
|
Net cash used in investing activities |
|
|
(60,993 |
) |
|
|
(43,892 |
) |
|
|
|
|
|
Cash Flow from Financing
Activities: |
|
|
|
|
Repurchase of shares |
|
|
(90,020 |
) |
|
|
(99,182 |
) |
Proceeds from employee stock options exercised |
|
|
41,178 |
|
|
|
8,379 |
|
Payments of dividends |
|
|
(38,413 |
) |
|
|
(35,046 |
) |
Payment of contingent consideration from a business
acquisition |
|
|
(1,411 |
) |
|
|
- |
|
Other |
|
|
(6 |
) |
|
|
(35 |
) |
Net cash used in financing activities |
|
|
(88,672 |
) |
|
|
(125,884 |
) |
|
|
|
|
|
Net increase (decrease) in cash and cash equivalents |
|
|
14,243 |
|
|
|
(60,126 |
) |
Cash and cash equivalents at beginning of period |
|
|
471,632 |
|
|
|
418,783 |
|
Cash and cash equivalents at end of period |
|
$ |
485,875 |
|
|
$ |
358,657 |
|
|
|
|
|
|
|
|
|
|
(*) The amounts under "Purchase of property and
equipment, net”, include proceeds from sale of property and
equipment of $373 and $31, for the three months ended 31 December
2019 and 2018, respectively.
|
AMDOCS LIMITEDSupplementary
Information(In millions) |
|
|
|
|
|
Three months ended |
|
|
December 31,2019 |
|
September 30, 2019 |
|
June 30, 2019 |
|
March 31, 2019 |
|
December 31,2018 |
North
America |
|
$ |
662.1 |
|
$ |
644.2 |
|
$ |
643.9 |
|
$ |
634.2 |
|
$ |
660.5 |
Europe |
|
|
154.7 |
|
|
156.1 |
|
|
145.5 |
|
|
151.0 |
|
|
146.1 |
Rest of the World |
|
|
225.2 |
|
|
230.0 |
|
|
235.3 |
|
|
234.5 |
|
|
205.5 |
Total Revenue |
|
$ |
1,042.0 |
|
$ |
1,030.3 |
|
$ |
1,024.7 |
|
$ |
1,019.7 |
|
$ |
1,012.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
December 31,2019 |
|
September 30, 2019 |
|
June 30, 2019 |
|
March 31, 2019 |
|
December 31,2018 |
Managed
Services Revenue |
|
$ |
579.7 |
|
$ |
583.3 |
|
$ |
578.1 |
|
$ |
559.5 |
|
$ |
525.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of |
|
|
December 31,2019 |
|
September 30, 2019 |
|
June 30, 2019 |
|
March 31, 2019 |
|
December 31, 2018 |
12-Month Backlog |
|
$ |
3,520 |
|
$ |
3,490 |
|
$ |
3,400 |
|
$ |
3,390 |
|
$ |
3,370 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amdocs (NASDAQ:DOX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amdocs (NASDAQ:DOX)
Historical Stock Chart
From Jul 2023 to Jul 2024